Guidance

COVID-19 vaccination: blood clotting information for healthcare professionals

Information for healthcare professionals on blood clotting following COVID-19 vaccination.

Applies to England

Documents

Details

Information for healthcare professionals on blood clotting following coronavirus (COVID-19) vaccination.

This publication is subject to extensive and regular revisions and we recommend linking to the latest version to ensure that you are giving the most up-to-date clinical advice and guidance.

Updates to this page

Published 7 April 2021
Last updated 14 February 2022 + show all updates
  1. Updated to include information on the risk of relapse of thrombosis and thrombocytopenia symptoms and risk of new or relapse of immune thrombocytopenic purpura following COVID-19 vaccinations.

  2. Added print version.

  3. Updated guidance document.

  4. Updated to include: antiphospholipid syndrome, interchangeability of COVID-19 vaccines, samples required for whole genome sequencing and the latest MHRA data.

  5. Updated information for healthcare professionals on blood clotting following COVID-19 vaccination.

  6. Updated sections: 13, 14, 16, 17, 19, 21 and 22.

  7. Added print version.

  8. First published.

Sign up for emails or print this page